Status:
COMPLETED
Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19
Lead Sponsor:
Dalarna County Council, Sweden
Conditions:
Corona Virus Infection
Virus Diseases
Eligibility:
All Genders
18-80 years
Brief Summary
This observational study will describe lung ultrasound (LUS) findings over time in hospitalized patients with moderate to severe Covid-19 lung disease. Our primary aim is to investigate if lung ultras...
Detailed Description
Study patients with moderate to severe Covid-19 infection will be screened with lung ultrasound daily. Lung ultrasound will be assessed by LUS-score for acute respiratory distress syndrome (ARDS) (0-3...
Eligibility Criteria
Inclusion
- Covid-19 confirmed by positive polymerase chain reaction (PCR)
- oxygen by mask or nasal prongs ≥ 4 l/min or high flow nasal cannula (HFNC) with fraction of inspired oxygen (FiO2) ≥ 30%
- age between 18-80 years
- informed consent
Exclusion
- patients subject to treatment-limitation "no ICU"
- history of heart failure
- history of lung disease e.g.: pneumonectomy, pulmonary fibrosis or other interstitial lung disease, pleurodesis
- history of kidney failure requiring dialysis
- any reason making lung ultrasound or daily follow up impossible
- opposition to participation in the study
Key Trial Info
Start Date :
May 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04412551
Start Date
May 20 2020
End Date
December 31 2020
Last Update
May 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Falun Hospital
Falun, Sweden